uromune
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 6, 2019 (NCT04096820)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Enterococcus faecalisImmunity, active
Enterococcus faecalis immunity, active
- Proteus vulgarisImmunity, active
Proteus vulgaris immunity, active
- Klebsiella pneumoniaeImmunity, active
Klebsiella pneumoniae immunity, active
- Escherichia coliImmunity, active
Escherichia coli immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04096820 | Phase 2 | Sep 6, 2019 | Queen's University, Belfast |
| NCT04173013 | N/A | — | Inmunotek S.L., myTomorrows |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Inmunotek S.L. | For profit | 1 | 0 | 1 | — |
| myTomorrows | Academic/Hospital | 1 | 1 | 1 | — |
| Queen's University, Belfast | Academic/Hospital | 1 | 1 | 1 | 2019 |
3 organizations
Page 1 / 1